Catalyst Wire Dossier Catalyst Wire Dossier

QAX028

· Novartis
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for QAX028, covering 2011-04-28 to 2020-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Multiple Doses of QAX028 in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]

See pricing